Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $671,687 - $883,310
18,596 Added 17.84%
122,854 $4.92 Million
Q1 2023

May 15, 2023

SELL
$35.53 - $43.38 $4,014 - $4,901
-113 Reduced 0.11%
104,258 $4.25 Million
Q4 2022

Feb 14, 2023

SELL
$38.19 - $57.45 $6.53 Million - $9.83 Million
-171,080 Reduced 62.11%
104,371 $4.03 Million
Q3 2022

Nov 14, 2022

SELL
$51.24 - $58.89 $761,375 - $875,046
-14,859 Reduced 5.12%
275,451 $14.7 Million
Q2 2022

Aug 15, 2022

SELL
$51.49 - $81.64 $408,109 - $647,078
-7,926 Reduced 2.66%
290,310 $16.9 Million
Q1 2022

May 16, 2022

SELL
$60.03 - $76.49 $3.38 Million - $4.31 Million
-56,370 Reduced 15.9%
298,236 $22.8 Million
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $3.77 Million - $4.89 Million
78,559 Added 28.46%
354,606 $21.3 Million
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $902,051 - $1.01 Million
-16,509 Reduced 5.64%
276,047 $15.5 Million
Q2 2021

Aug 16, 2021

SELL
$59.18 - $69.99 $1.2 Million - $1.42 Million
-20,288 Reduced 6.49%
292,556 $17.8 Million
Q1 2021

May 17, 2021

SELL
$59.31 - $78.82 $6.41 Million - $8.52 Million
-108,123 Reduced 25.68%
312,844 $21.9 Million
Q4 2020

Feb 16, 2021

BUY
$50.47 - $66.26 $1.09 Million - $1.43 Million
21,648 Added 5.42%
420,967 $25.2 Million
Q3 2020

Nov 16, 2020

BUY
$51.97 - $63.0 $10.4 Million - $12.7 Million
200,871 Added 101.22%
399,319 $24 Million
Q2 2020

Aug 14, 2020

SELL
$30.8 - $52.47 $108,816 - $185,376
-3,533 Reduced 1.75%
198,448 $10.4 Million
Q1 2020

May 15, 2020

BUY
$28.4 - $50.7 $703,837 - $1.26 Million
24,783 Added 13.99%
201,981 $6.77 Million
Q4 2019

Feb 14, 2020

SELL
$36.31 - $46.83 $273,123 - $352,255
-7,522 Reduced 4.07%
177,198 $8.03 Million
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $6.59 Million - $8.31 Million
184,720 New
184,720 $7.03 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $870M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.